Hostname: page-component-586b7cd67f-dsjbd Total loading time: 0 Render date: 2024-11-24T18:50:57.387Z Has data issue: false hasContentIssue false
  • English
  • Français

Full fat cheese intake and cardiovascular health: a randomised control trial

Published online by Cambridge University Press:  11 December 2017

T.J. Butler ,
I. Davies  and
S. Mushtaq
T.J. Butler
Affiliation:
Department of Clinical Sciences and Nutrition, University of Chester, Chester, CH1 4BJ Department of Health Professions, Manchester Metropolitan University, Manchester, M15 6BG
I. Davies
Affiliation:
School of Sport Studies, Leisure and Nutrition, LJMU, Liverpool, L2 2ER
S. Mushtaq
Affiliation:
Department of Health Professions, Manchester Metropolitan University, Manchester, M15 6BG
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.
Type
Abstract
Information
Proceedings of the Nutrition Society , Volume 76 , Issue OCE4: Summer Meeting, 10–12 July 2017, Improving Nutrition in Metropolitan Areas , 2017 , E223
Copyright
Copyright © The Authors 2017 

Milk and milk products contribute approximately 22 % of the nation's saturated fat (SFA) intake. Recently, the role of dairy and its SFA composition and link to cardiovascular disease (CVD) has been analysed( Reference Lovegrove and Hobbs 1 ), suggesting a beneficial action of this food group on reducing cardiovascular risk in high-risk groups( Reference Díaz-López, Bulló and Martínez-González 2 , Reference Nilsen, Høstmark and Haug 3 ). The aim of this study was to examine the effects of 4 weeks full-fat cheese on circulating lipoprotein fractions, blood pressure and arterial stiffness in healthy adults.

Participants were recruited in the city of Chester, UK. Those meeting entry criteria of: 18–65 years of age, not taking antihypercholesterolaemic or antihypertensive medication took part in the study. Participants were randomised to receive either 50 g of a full-fat Red Leicester (FFC) or placebo (virtually zero fat Cheddar cheese, ZFC) per day for 4 weeks. Anthropometry, blood pressure, brachial and aortic augmentation index (BAIX and AAIX, respectively), pulse-wave velocity (PWV) and a full lipid profile were determined at baseline and post-intervention. Participants were asked to keep a 3-day food diary prior to and for the last 3 days of the protocol. All procedures were approved by the Faculty of Medicine, Dentistry and Life Sciences Research Ethics Committee at the University of Chester.

Table 1. Baseline (T0) and follow-up (T1) measurements

T0, baseline; T1 follow-up, LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein-cholesterol; BAIX, brachial augmentation index; AAIX, aortic augmentation index; PWV, pulse-wave velocity. Data show mean ± SD.

Eighty-six (86) individuals completed the study (43 per group). No significant changes were observed in any measured parameter (Table 1). Both ZFC and FFC groups showed a significant increase in calcium intake during the course of the study (1002·1 ± 639·1 mg to 1815·0 ± 1340·1 mg and 1219·6 ± 1169·1 mg 1845·8 ± 1463·2 mg, P < 0·001, respectively) showing good adherence to the protocol.

In conclusion, these results suggest that inclusion of 50 g full fat cheese into the diet of a healthy population does not impact negatively on traditional CVD risk markers. Future strategies to reduce SFA intake should focus on – and acknowledge the importance of the source – of SFA in the diet.

References

1. Lovegrove, JA, Hobbs, DA (2016) Proc Nutr Soc 75, 247–258.CrossRefGoogle Scholar
2. Díaz-López, A, Bulló, M, Martínez-González, MA et al. (2016) Eur J Nutr 55, 349–360.CrossRefGoogle Scholar
3. Nilsen, R, Høstmark, AT, Haug, A et al. (2015) Food Nutr Res 59, 27651.CrossRefGoogle Scholar
Figure 0

Table 1. Baseline (T0) and follow-up (T1) measurements